Corrigendum: Effects on subclinical heart failure in type 2 diabetic subjects on Liraglutide Treatment vs. Glimepiride Both in combination with metformin: A randomized open parallel-group study [Front Endocrinol, 8, (2017) (325)] DOI: 10.3389/fendo.2017.00325

Abstract

A corrigendum on Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study by Nyström T, Santos-Pardo I, Hedberg F, Wardell J, Witt N, Cao Y, et al. Front Endocrinol (2017) 8:325. doi: 10.3389/fendo.2017.00325 One of the authors name, Irene Santos-Pardo, was misspelled in the published manuscript (as Irene Padro Santos). The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way. The original article was updated.